Sage Therapeutics

SAGE THERAPEUTICS INC

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

Wall street sign in New York

Analyst Color

Asia

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Earnings

Earnings Beats

Earnings Misses

Equities

Government

Macro Economic Events

Macro Notification

Market Summary

News

Regulations

Bonds

Broad U.S. Equity ETFs

Guidance

Eurozone

Futures

Commodities

Forex

Treasuries

Economics

Federal Reserve

Pre-Market Outlook

Markets

Analyst Ratings

ETFs

General

$BTC

AMZN

AREB

AURA

GOOG

LULU

SAGE

SLNO

U.S. stock futures were swinging between gains and losses on Thursday after snapping a three-day winning streak on Wednesday. Futures of major benchmark indices were mixed in premarket trading.



Aiming to boost U.S. manufacturing and reduce reliance on global suppliers, new auto tariffs were introduced on Wednesday, which will go into effect from April 3.

US Stocks Likely To Open Mixed: &#39;Expect Volatility. Buckle Up,&#39; Says Expert

Movers_Stocks

Movers

Trading Ideas

MTSR

OKLO

QFIN

KB Home Posts Downbeat Results, Joins UniFirst, Oklo And Other Big Stocks Moving Lower In Tuesday&#39;s Pre-Market Session

Stock Movers

ATOM

DGLY

Faraday Future Intelligent Electric Inc. - Class A Common Stock

FFAI

FUFU

IMTE

MULN

MURA

Orchestra BioMed Holdings, Inc. - Ordinary Shares

OBIO

PROP

PSIX

STFS

TNON

TOPP

TRSG

VVPR

XHLD

Why Power Solutions International Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket

Sage Therapeutics Inc

SAGEN MI CDA INC PFD A by SAGEN MI CDA INC.

Sage Gold Inc

Sage Group (The) PLC

SAGE GROUP UNSP/ADR by Sage Group plc (The)

Sage Potash Corp

Legal

Press Releases

Long-Term Shareholder Notice: Fluence Energy, Inc. (NASDAQ: FLNC); Kyverna Therapuetics, Inc. (NASDAQ: KYTX); Mercury Systems, Inc. (NASDAQ: MRCY); and Sage Therapeutics, Inc. (NASDAQ: SAGE): Grabar Law Office Investigates Claims on Your Behalf

Notice to Long-Term Shareholders of Mercury Systems, Inc. (NASDAQ: MRCY); Methode Electronics, Inc. (NYSE: MEI); Monolithic Power Systems, Inc. (NASDAQ: MPWR); and Sage Therapeutics, Inc. (NASDAQ: SAGE): Grabar Law Office Investigates Claims on Your Behalf

SAGE THERAPEUTICS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Sage Therapeutics, Inc. - SAGE

Notice to Long-Term Shareholders of Fluence Energy, Inc. (NASDAQ: FLNC); Kyverna Therapuetics, Inc. (NASDAQ: KYTX); Mercury Systems, Inc. (NASDAQ: MRCY); and Sage Therapeutics, Inc. (NASDAQ: SAGE): Grabar Law Office Is Investigating Claims on Your Behalf

SAGE THERAPEUTICS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Sage Therapeutics, Inc. - SAGE

SAGE SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Sage Therapeutics, Inc. (NASDAQ: SAGE) and Encourages Long-Term SAGE Investors to Contact the Firm

Sage Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, April 29, 2025

Kuehn Law Encourages Investors of Sage Therapeutics, Inc. to Contact Law Firm

Sage Therapeutics Announces First Quarter 2025 Financial Results and Highlights Pipeline and Business Updates

FLNC

KYTX

MPWR

MRCY

Abivax

Altimmune

Capricor Therapeutics, Inc. - Common Stock

Capricor Therapeutics

Celcuity

Cullinan Therapeutics, Inc. - Common Stock

Cullinan Therapeutics

Inventiva S.A. - American Depository Shares

Inventiva

Jade Biosciences

Kura Oncology

MeiraGTx Hldgs

Myriad Genetics

Organogenesis Holdings

Precigen

PureTech Health plc - American Depositary Shares

PureTech Health

Regenxbio

Relay Therapeutics

Sana Biotechnology

Stoke Therapeutics

Tectonic Therapeutic, Inc. - Common Stock

Tectonic Therapeutic

Tourmaline Bio

Taysha Gene Therapies, Inc. - Common Stock

Taysha Gene Therapies

Tyra Biosciences

Upstream Bio

Valneva

Verve Therapeutics

Verastem

Scotiabank

Wedbush

Canaccord Genuity

HC Wainwright & Co.

Piper Sandler

Comments

Sage Therapeutics

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell